Skip to main content
Download PDF

Fine particulate matter contributes to COPD-like pathophysiology: experimental evidence from rats exposed to diesel exhaust particles

Respiratory Research volume 25, Article number: 14 (2024) Cite this article

Abstract

Background

Ambient fine particulate matter (PM2.5) is considered a plausible contributor to the onset of chronic obstructive pulmonary disease (COPD). Mechanistic studies are needed to augment the causality of epidemiologic findings. In this study, we aimed to test the hypothesis that repeated exposure to diesel exhaust particles (DEP), a model PM2.5, causes COPD-like pathophysiologic alterations, consequently leading to the development of specific disease phenotypes. Sprague Dawley rats, representing healthy lungs, were randomly assigned to inhale filtered clean air or DEP at a steady-state concentration of 1.03 mg/m3 (mass concentration), 4 h per day, consecutively for 2, 4, and 8 weeks, respectively. Pulmonary inflammation, morphologies and function were examined.

Results

Black carbon (a component of DEP) loading in bronchoalveolar lavage macrophages demonstrated a dose-dependent increase in rats following DEP exposures of different durations, indicating that DEP deposited and accumulated in the peripheral lung. Total wall areas (WAt) of small airways, but not of large airways, were significantly increased following DEP exposures, compared to those following filtered air exposures. Consistently, the expression of α-smooth muscle actin (α-SMA) in peripheral lung was elevated following DEP exposures. Fibrosis areas surrounding the small airways and content of hydroxyproline in lung tissue increased significantly following 4-week and 8-week DEP exposure as compared to the filtered air controls. In addition, goblet cell hyperplasia and mucus hypersecretions were evident in small airways following 4-week and 8-week DEP exposures. Lung resistance and total lung capacity were significantly increased following DEP exposures. Serum levels of two oxidative stress biomarkers (MDA and 8-OHdG) were significantly increased. A dramatical recruitment of eosinophils (14.0-fold increase over the control) and macrophages (3.2-fold increase) to the submucosa area of small airways was observed following DEP exposures.

Conclusions

DEP exposures over the courses of 2 to 8 weeks induced COPD-like pathophysiology in rats, with characteristic small airway remodeling, mucus hypersecretion, and eosinophilic inflammation. The results provide insights on the pathophysiologic mechanisms by which PM2.5 exposures cause COPD especially the eosinophilic phenotype.

Background

Chronic obstructive pulmonary disease (COPD) has become the third leading cause of death worldwide and its prevalence is still on the rise [1]. Exposure to noxious particles and gases is considered a main cause of COPD. Among those, tobacco smoking is a confirmed and major etiology of COPD globally [2]. However, up to 45% COPD patients have never smoked, and about 26–53% of the COPD cases may be attributed to other environmental exposures [3,4,5]. For example, a large nationwide cross-sectional study in China found that exposure to high ambient concentrations of fine particulate matter (PM2.5: particulate matter with aerodynamic diameter < 2.5 μm) significantly increased the prevalence of COPD by two-fold [6]. Additionally, some large cohort studies have revealed positive associations of long-term ambient PM2.5 exposure and higher incidence and prevalence of COPD [7, 8]. People residing close to the urban traffic have been significantly associated with a higher risk of having COPD [9, 10]. However, the epidemiology on PM2.5 as an COPD etiology is still elusive. In a recent official American Thoracic Society (ATS) workshop report, ambient PM2.5 is considered as a plausible contributor to the onset of COPD [11]. More mechanistic studies are needed to ascertain the causal role of chronic exposure to PM2.5 in the development of COPD and related phenotypes.

COPD is a heterogeneous disease characterized by fixed airflow limitation. Small airway remodeling and emphysematous destruction are two main pathologic features of this disease. Two seminal studies have shown that small airways are the primary site for airflow limitation, and that dysfunction of the small airways contributed significantly to airflow limitation in patients with COPD [12, 13]. Emerging epidemiologic studies have recently shown associations between ambient air pollution, especially PM2.5, and small airway dysfunction. In a nationwide survey, Xiao et al. revealed that spirometry-defined small airway dysfunction was significantly associated with exposure to high level of ambient PM2.5 [14]. Two indoor air filtration studies reported that reduced PM2.5 exposure was significantly associated with improved small airway mechanics in young adults [15] and in children [16]. However, a direct link between PM2.5 effects on the small airway and COPD pathogenesis is yet to be established, which is difficult to do in epidemiologic studies. Hence, we designed the present experimental study to test our hypothesis that repeat exposure to ambient PM2.5 causes small airway remodeling as the primary site of injury, consequently leading to the development of experimental COPD.

It is known that inflammatory phenotypes play an important role in COPD pathogenesis. Cigarette smoke-related COPD is usually characterized by a neutrophilic-dominant inflammatory phenotype, while biomass smoke-related COPD can manifest as eosinophilic-biased airway inflammation [17, 18]. However, the effect of PM2.5 on inflammatory phenotypes of COPD remains unknown. We, hence, aim to investigate COPD phenotypes (e.g., eosinophilic versus neutrophilic) that are more likely to be induced by fine particulate matter exposure.

Diesel exhaust particles (DEP) generated by traffic vehicles are a major source of ambient PM2.5 in urban areas. Freshly generated DEP contains fine and ultrafine particles coated by complex hazardous components, and has been used as a model PM2.5 in numerous toxicological studies [19, 20]. Experimental evidence has shown that inhaled aerosol particles ranged in smaller sizes deposited mainly in the small airways of rodents [21, 22]. In this regard, DEP represents an ideal model to investigate the injury in the small airways and will be used in the present study. Using our established DEP inhalation exposure protocol for rats [23], we will evaluate COPD-relevant morphologic changes of various compartments of the airways, airway inflammation and lung function, following DEP exposures of various durations.

Materials and methods

Experimental animals

A total of 36 Male Sprague Dawley (SD) rats (6 weeks old with body weight around 200 g) were purchased from the Guangdong Medical Laboratory Animal Center (Foshan, China). All animals were housed in pathogen-free facilities. The animals were maintained in standard cages with food and water available ad libitum. Animals were divided into six groups by exposure condition, including the filtered-air controls, 2-week (wk) DEP exposure, 4-wk DEP exposure and 8-wk DEP exposure. Each group had 6 rats. The animal experimental protocols were approved by the Animal Care and Use Committee of Guangzhou Medical University and confirmed to the Guide for the Care and Use of Laboratory Animals.

DEP exposure protocol

The DEP generator and exposure chamber are shown in Fig. 1A. In brief, the exposure chamber had size dimensions of 3.3 m × 2.2 m × 2.2 m. The walls inside the exposure chamber were coated with Teflon. Filtered air was introduced into the chamber through an air pump (2.5 L/min) located above the ceiling of the room. Fresh diesel exhaust particles (DEP) were generated by a 2.0 L diesel automotive engine (Nissan, M1D, Japan), using diesel fuel (Sinopec Corp., #0, China). A small fan was running inside the tightly-enclosed chamber to mix the DEP uniformly during the experiment. An exhaust fan connected to a ventilating duct was installed to allow the rapid discharge of the gaseous pollutants. DEP concentrations were maintained at a steady-state in the chamber.

Fig. 1
figure 1

Study protocol and structural changes in different compartments of rat lung. The DEP generator and exposure chamber were shown in (A), while the schema of study protocol was demonstrated in (B). Total wall area (WAt) of large airways showing no significant difference following 2-wk, 4-wk and 8-wk DEP exposures, respectively, as compared to the filtered air controls (C-D). DEP exposures for three durations induced significant increases in WAt of small airways (E-F). Compared to the filtered air control, 4-wk and 8-wk DEP exposures, respectively, resulted in significant increases in MLI of alveoli (G-H). Data were expressed as mean (95% CI). ns = not significant, *** p < 0.001. n = 6 rats/group. Bars in all the HE staining images = 100 μm

Full size image

The experimental protocol can be referred to Fig. 1B. In brief, the DEP-exposed rats were placed in the chamber to inhale freshly generated DEP, 4 h a day and 6 days a week, for consecutive 2, 4, or 8 weeks, respectively. Control rats were exposed to filtered ambient air under the same chamber settings. The temperature and relative humidity inside the chamber for all experiments were controlled at 21.0 °C and 60.0%, respectively.

Air pollutants measurements

During the exposure periods, DEP mass was collected onto quartz fiber filters (Whatman, QM-A, UK) using high-volume particulate matter samplers (Thermo, GUV-15HBL1, USA). DEP mass collected was determined gravimetrically by weighing the quartz filters before and after sampling; and particle mass concentrations (PMC) were calculated by dividing DEP mass by the air volume sampled. Particle number concentrations (PNC) of DEP were obtained by Dylos particle counting device (Dylos DC1700™, USA), of which has been validated to estimate the fine particulate matter concentration in a previous study [24]. Pollutant concentrations were measured at one-minute resolution during 4 h DEP exposures. Chemical components of DEP, e.g., organic carbon (OC), elemental carbon (EC), metal elements and polycyclic aromatic hydrocarbons (PAHs), were analyzed as described below.

Chemical analysis of DEP

A punch (1.5 × 1.0 cm) of each filter was taken for the measurements of OC and EC using a thermal/optical transmittance aerosol carbon analyzer (Sunset Laboratory Inc., OR, USA). For metal elements, the extraction and instrumental analyses were executed according to the method described previously [25]. Briefly, four punches (1.5 × 1.0 cm) of each filter were first extracted in a digestion bomb (CEM Corp., XP-1500, USA) with a mixture of 4 ml of HNO3 (Merck Corp., Germany), 1 ml of HCl (Guangzhou Chemical Reagent Factory, China), and 0.2 ml of HF (Guangzhou Chemical Reagent Factory, China), and digested by a microwave digestion unit (CEM Corp., MARS 5, USA). The digestion was carried out at 175 °C for 25 min. The resulting solution was diluted to 50 ml with ultra-pure water generated from a Milli-Q system (Millipore Corp., USA). The final solutions were measured by an ICP-MS equipped with a Babington nebulizer (Agilent Corp., 7700X, USA). For measuring PAHs, filters were extracted with 30 mL dichloromethane (Merck Corp., Germany) using ultrasonic agitation under 30 °C and filtered. This extraction procedure was repeated three times. The combined extracts were filtered and concentrated by rotary evaporation under vacuum. Each sample was concentrated to about 0.5 mL. Interfering compounds were removed by liquid-solid chromatography using 2:1 silica-alumina column. Two fractions were eluted. Fraction I (40 mL of hexane) contained n-alkanes, hopanes and steranes (Merck Corp., Germany), while fraction II (100 mL of DCM-hexane (1:1)) contained the priority PAHs. Then under a gentle stream of nitrogen, fraction I and fraction II were reduced almost to dryness and redissolved with 100 μL n-hexane. The two fractions were analyzed on GC-MS (Agilent Corp., 6890 − 5973 N, USA).

BALF cell differentiation, cytokine quantification and carbon loading measurement

Rat’s lung was lavaged with 2 ml saline for three times to obtain a total volume of about 5 ml bronchoalveolar lavage fluid (BALF). BALF cells were collected then stained with hematoxylin and eosin (H&E) for differential counting of leukocytes under microscopy. At least 400 cells per slide were counted. Multiple cytokines in the BALF supernatant were measured by ELISA (R&D Systems, USA). Under light microscope, high-magnification figures were taken to measure the area of black carbon phagocyted by macrophages. The quantification analysis was performed with ImageScope software (Leica Biosystems, v.11, German). At least 10 fields in each slide were examined in a blinded manner.

Histological evaluation

After obtaining the BAL fluid, right upper lungs were removed and fixed in 10% buffered formalin. The tissue samples were cut into 4-μm sections and affixed onto microscope slides and deparaffinized. Lung sections were stained with H&E for morphologic analysis. For identification of mucus-containing cells, Periodic Acid-Schiff (PAS) staining was applied. PAS-positive cells were counted in superficial epithelia of the small airways (perimeter < 1000 μm). Quantification analysis was determined by dividing the PAS-positive cells by the length of basement membrane (BM) of the small airways. For immunohistochemistry evaluation, sections were incubated with mouse monoclonal primary antibody, MUC5AC (Abcam, #Ab3649, UK), at 4 °C overnight. Following washes, the sections were measured by a two-step detection system (ZSGB-Bio, #PV-9000, China) according to manufacturer’s instructions. Subepithelial fibrosis was determined by evaluation of Masson’s Trichrome staining of the lung sections. Fibrotic area surrounding the small airways (perimeter < 1000 μm) was determined by image-pro plus 6.0 software (Media Cybernetics, USA). The total fibrotic area divided by the length of basement membrane (BM) was calculated. For evaluating airway remodeling, immunofluorescent staining was utilized. Sections were incubated with mouse monoclonal primary antibody, α-SMA (Novus Biologicals, #NB300-978, USA), at 4 °C overnight. Following washes, the sections were incubated with a secondary antibody (Abcam, #ab6881, UK). The sections were viewed under a laser confocal microscope (Nikon, C1Si, Japan).

Morphometrical analysis of different airway compartments

The airway structure of rats differs significantly from that of humans. According to previous reports [26, 27], the small airway of rats was defined as perimeter of basement membrane (Pbm) ≤ 1000 μm, whereas the large-size airways were defined as Pbm of > 2000 μm, respectively (Supplementary Fig. 1). In this study, the small airways of rats included membranous bronchioles and respiratory bronchioles. Panoramic images of HE-stained lung section were acquired via Aperio digital pathologic image scanner (Leica Biosystems, German). The morphological analysis of the lung was performed using ImageScope viewing software (Leica Biosystems, German). According to a previous study in quantifying the area of airway wall [28], the total airway wall area (WAt) of each airway was calculated as WAt = Outer wall area (WAo) - Inner wall area (WAi). The relative area of each airway was calculated by dividing WAt by the length of the basement membrane (BM) of the airway. At least 10 different airways per section were analyzed. The mean linear intercept (MLI), a measurement of interalveolar septal wall distance, was determined using a reticule with a Thurlbeck grid comprising of 5 lines (each 550 μm long), with at least 10 fields assessed per section. The MLI was calculated through dividing the length of the line by the number of alveolar wall and gridline interception counted. At least 10 different peripheral lung parenchyma per section were analyzed.

Determination of inflammatory cells in lung tissue

Macrophages and neutrophils were labelled with specific marker Ibal-1 (Wako, #019-19741, Japan) and Neutrophil elastase (Abcam, #ab310335, UK), respectively, using the standard immunohistochemistry (IHC) staining protocol. For eosinophil-specific staining, sections were stained for 30 min with chromotrope 2R (Sigma-Aldrich, #4197-07-3, USA) solution (1% chromotrope 2R in 5% phenol), by which the eosinophils were specifically stained in red. Another specific staining with 1% toluidine blue (Sigma-Aldrich, #6586-04-5, USA) was utilized to detect mast cells (MCs) cytoplasmic granules. All sections were examined under light microscopy. The numbers of Ibal-1 positive cells, elastase positive cells, eosinophils and mast cells were quantified according to the NIH Image Analysis system (National Institutes of Health, Bethesda, MD). The inflammatory cells around the airways were expressed as cells per millimeter (mm) basement membrane. At least 10 fields in each slide were examined in a blinded manner.

Measurement of lung hydroxyproline content and systemic oxidative stress

The lower right lungs were analyzed for hydroxyproline content as an estimate of collagen content using Colorimetric Assay Kit (BioVision, #K555-100, USA). Detailed method has been described in our previous study [29].

Blood samples were taken from the left heart using a syringe with 25G needle and collected into tubes, then left to clot at 4ºC followed by centrifugation at 4ºC, 2400 g, for 10 min. Serum samples, stored at -80ºC before analysis, were analyzed for malondialdehyde (MDA) and 8-hydroxy-2’-deoxyguanosine (8-OHdG) using published HPLC and LC-MS/MS method [30].

Lung function measurement

Lung function was measured using the Forced Pulmonary Maneuver System (Buxico Research Systems, USA). Rats anesthetized with pentobarbital (60 mg/kg body), were tracheostomized, intubated and placed in the body chamber of the system. The average breathing frequency was set to 80 breathes/min. Resistance and compliance were determined by measuring tracheal pressure and flow continuously during ventilation. To determine the total lung capacity (TLC), a quasi-static pressure volume maneuver was performed, by which the lungs were inflated to a standard pressure of + 30 cm H2O and then slowly exhales until a negative pressure of -30 cm H2O is reached.

Statistical analysis

For the comparison of BALF cell count, pathological parameters, infiltration of inflammatory cells, level of inflammatory mediators, lung function parameters and carbon loading areas, data were shown as mean (95% CI). One-way analysis of variance (ANOVA) test and Tukey’s multiple comparisons test were used to determine the differences among groups. Statistical differences between the two groups were analyzed by Student t-test. Statistical significance was set at P < 0.05. All analyses were performed with the Prism software (GraphPad Software, version 9.0, USA).

Results

Exposure characteristics

During the DEP exposure period, changing trends of particle mass concentration (PMC) and particle number concentration (PNC) were shown in Fig. 2. A total of 240 data points were measured during 4-hour DEP exposure. The average levels (95% CI) of PMC and PNC were 1.03 mg/m3 (range: 0.99–1.07 mg/m3) and 1.36 × 108 (1.33 ~ 1.38 × 108 /m³), respectively. In addition, PMC was correlated significantly with PNC during the exposure period (p < 0.0001). The PMC in the exposure chamber was nearly 25-fold compared to that in filtered air environment of 0.042 mg/m3 (0.036–0.047 mg/m3).

Fig. 2
figure 2

Changing trend of DEP concentrations during exposure period. The changing trends of particle mass concentration (PMC, A) and particle number concentration (PNC, B) during 4 h DEP exposures were shown. Correlation analysis showed that the changing trend of PMC was significantly correlated with that of PNC during the exposure period (C, r2 = 0.96, p < 0.0001)

Full size image

The chemical composition analysis showed that OC and EC accounted for 76.74% and 20.69% of the total DEP mass, respectively. We identified 25 metal elements and 25 PAHs, accounting for 0.71% and 0.37% of DEP mass, respectively. The most abundant metal elements were Na and Ca, followed by Mg, Al and K. The presence of redox-active transition metals (e.g., Fe, Cu, Zn, Ag, Cr, Mn, Cd) was evident (Table 1). Among the PAHs, benzo(ghi)perylene, Chrysene/Tri-phenylene and benzo(a)pyrene were most abundant (Table 2).

Table 1 Concentrations of metal elements in DEP
Full size table
Table 2 Concentrations of PAHs in DEP
Full size table

DEP exposure induced COPD-like pathologies

To determine whether DEP exposures can induce COPD-like pathologies, we performed histological evaluations. We did not observe significant changes of the total wall area (WAt) in large airways following DEP exposures (Fig. 1. C-D). In contrast, there were about 2-fold increase in WAt of the small airways following DEP exposures for 2 weeks [WAt/BM, 35.2 (32.5 ~ 37.9) μm2 vs. 20.2 (16.7 ~ 23.8) μm2], 4 weeks [39.2 (34.3–40.1) μm2 vs. 21.5 (19.5 ~ 23.6) μm2], and 8 weeks [41.8 (35.8–47.9) μm2 vs. 19.2 (18.0-20.4) μm2] (Fig. 1. E, F). Following 2-week DEP exposure, MLI in the alveoli region showed an increase trend without statistical significance, as compared to the filtered air control. Following the longer exposure durations, however, MLI had increased significantly [89.7 (81.1–98.4) μm vs. 48.1 (45.1–51.3) μm, for 4-wk exposure] and [101.8 (87.3–116.0) μm vs. 51.1 (45.5 ~ 56.7) μm, for 8-wk exposure] (Fig. 1. G, H).

Carbon loading is elevated in alveolar macrophages

In order to quantify the exposure level upon inhalation exposure to DEP, we measured the area of carbon loading in rats’ alveolar macrophages. The results showed that inhaled elemental carbon (EC or black carbon) was taken up by alveolar macrophages in a dose-dependent manner. The areas showing black carbon uptake in BAL macrophages were increased significantly to 2.5 (1.2 ~ 3.8) μm2, 4.8 (4.2 ~ 5.4) μm2, and 7.0 (5.5 ~ 8.5) μm2 following DEP exposures for 2, 4, and 8 weeks, respectively, compared to those exposed to filtered air (Fig. 3, A-B).

Fig. 3
figure 3

Carbon loading in alveolar macrophages and lung function parameters. Carbon uptake areas in BALF macrophages (A, red arrows) following DEP exposures for 2-wk, 4-wk and 8-wk significantly increased, in a dose-dependent manner, compared to carbon uptake areas following filtered air exposure (*** p < 0.001, ## p < 0.01, ### p < 0.001, B). Bar = 8 μm. Total lung capacity (TLC) increased significantly following 2-wk, 4-wk and 8-wk DEP exposures as compared to filtered air controls, respectively (** p < 0.01, C). Also, lung resistance increased significantly following 4-wk and 8-wk DEP exposures, respectively (** p < 0.01, D). Data were expressed as mean (95% CI). ns = not significant

Full size image

DEP exposure induced lung function impairments

To determine the changes in lung function, we measured lung function parameters of rats following exposures to DEP or filtered air. Total lung capacity (TLC) was significantly increased following each of the 3 DEP exposures in reference to the filtered air control: [14.9 (13.4–16.5) ml vs. 11.3 (10.2–12.4) ml for 2-wk exposure], [19.0 (18.3–19.7) ml vs. 15.7 (13.8–17.6) ml for 4-wk exposure], and [19.0 (18.0–20.0) ml vs. 15.9 (14.2–17.6) ml for 8-wk exposure] (Fig. 3. C). Also noted were the increases in lung resistance (Rl) following the 4-wk or the 8-wk DEP exposure (Fig. 3. D). Although 2-wk DEP exposure appeared to increase Rl without a statistical significance, longer-duration exposures resulted in significant Rl increases [0.16 (0.13–0.18) vs. 0.13 (0.12–0.14) cm H2O s/ml for 4-wk exposure] and [0.16 (0.14–0.19) vs. 0.13 (0.11–0.13) cm H2O s/ml for 8-wk exposure].

DEP exposure induced remodeling and fibrosis of the peripheral lung

To determine the remodeling of peripheral lung, we measured α-SMA expression using rats’ lung slice by immunofluorescent staining. Of the small airways, positive expressions of α-SMA (positive area/total airway wall area) increased significantly following DEP exposures for 4 weeks [24.5% (21.3-27.6%) vs. 9.8% (6.4-13.2%)] and 8 weeks [24.7% (19.5-30.0%) vs. 9.7% (6.0-13.3%)], respectively (Fig. 4, A-B). In the alveolar region, relative to the filtered air control conditions, the number of positive cells expressing α‐SMA increased significantly following DEP exposures over 2 weeks [35.7 (26.7–44.6) cells/mm2 vs. 13.0 (9.5–16.4) cells/mm2], 4 weeks [63.3 (48.9–77.8) cells/mm2 vs. 13.7 (9.4–17.9) cells/mm2], and 8 weeks [72.5 (52.4–92.5) cells/mm2 vs. 16.3 (12.1–20.4) cells/mm2], respectively (Fig. 4, C-D).

Fig. 4
figure 4

Remodeling and fibrosis of the peripheral lung. Of the small airways, the relative expression of α-SMA (stained in green) of smooth muscle to total wall area increased significantly in DEP exposure for 4-wk and 8-wk, respectively (*** p < 0.001, A-B). In the alveolar region, the number of α-SMA positive cells (white arrow head, C) increased significantly post-DEP exposures (*** p < 0.001, D). The fibrosis areas (stained in blue, E) around the small airways also significantly increased following 4-wk and 8-wk DEP exposures, respectively (* p < 0.05, ** p < 0.01, F). The contents of hydroxyproline in lung tissue significantly increased in rats exposed to DEP for 4 weeks and 8 weeks, respectively (** p < 0.01, G). Data were expressed as mean (95% CI). Bars in the immunofluorescent staining images = 50 μm, while bar in the Masson Trichrome staining image = 100 μm. SA: small airways, ns = not significant

Full size image

To determine lung fibrosis upon DEP exposure, we measured lung hydroxyproline content and subepithelial fibrosis of different airway compartments. Following the 2-wk DEP exposure, areas of fibrosis around the small airways tended to increase in reference to the filtered air control, as we did not observe a difference of statistical significance. With longer DEP exposure durations, however, we observed significant increases of fibrotic area around the small airways for 4-week [7.7 × 104 (6.2 × 104 ~ 9.2 × 104) μm2 vs. 5.0 × 104 (3.1 × 104 ~ 6.9 × 104) μm2] and for 8-week [8.2 × 104 (7.2 × 104 ~ 9.2 × 104) μm2 vs. 5.7 × 104 (4.2 × 104 ~ 7.2 × 104) μm2] (Fig. 4. E-F). Consistently, levels of hydroxyproline protein increased significantly following DEP exposures for 4 weeks [4.7 (4.4–4.9) μg/ mg vs. 3.4 (2.7-4.0) μg/mg] and 8 weeks [6.1 (4.0-8.1) μg/mg vs. 3.9 (3.5–4.2) μg/mg] (Fig. 4. G). In sharp contrast, DEP exposures of any duration did not result in significant fibrotic changes of the large airways (Supplementary Fig. 2).

DEP exposure induced mucus hypersecretion and goblet cell hyperplasia of the small airways

To evaluate the epithelial cell morphology and mucus production, we performed Periodic Acid-Schiff (PAS) staining and immunohistochemical staining with anti-MUC5AC antibody using rats’ lung slice. As shown in Fig. 5A-B, the number of MUC5AC-positive cells in the small airway epithelia increased significantly following exposure to DEP for 4 weeks [1.06 (0.55–1.57) cells/ mm BM vs. 0.17 (0-0.60) cells/ mm BM] and 8 weeks [4.18 (1.51–6.85) cells/ mm BM vs. 0.25 (0-0.89) cells/ mm BM], indicating the involvement of mucus hypersecretion in this model. Consistently, relative to the filtered air controls, 4-week and 8-week DEP exposures caused a significant increase in the number of PAS-positive goblet cells of the superficial epithelia [4-week: 1.81 (1.18–2.44) cells/ mm BM vs. 0.22 (0-0.78) cells/ mm BM; 8-week: 6.67 (0.87–12.47) cells/ mm BM vs. 0.33 (0-1.17) cells/ mm BM], respectively (Fig. 5C, D), indicating the presence of airway goblet cell hyperplasia.

Fig. 5
figure 5

Mucus production and epithelial cell morphology of the small airways. The MUC5AC-immunopositive cells (red arrows, A) and PAS-positive goblet cells (blue arrows, C) were indicated. Quantification analysis showed that the number of MUC5AC positive cells of the superficial epithelia was increased significantly following DEP exposures over 4-wk and 8-wk (** p < 0.01, B). The number of PAS positive cells was also increased significantly following DEP exposures for 4-wk and 8-wk (** p < 0.01, D). Data were expressed as mean (95% CI). Magnification of the lower panel images in A and C, 1000 x, ns = not significant

Full size image

DEP exposure induced significant inflammatory cell recruitment to the lung

To determine the infiltrations of various immune cells, we performed specific staining or immunohistochemistry staining in lung slice. Exposure to DEP induced potent inflammatory responses of the peripheral lung. A dramatical increase of eosinophils around the small airways in DEP-exposed rats was observed. As compared to the filtered air controls, 4-wk and 8-wk DEP exposures caused a 6.5-fold increase [7.2 (2.2–12.6) vs. 1.1 (0.4–2.6)/mm BM] and a 14.0-fold increase [9.9 (1.8–17.8) vs. 0.7 (0.0-1.37)/mm BM] in eosinophils infiltration around the small airways, respectively (Fig. 6. A-B). In addition, recruitment of eosinophils to the alveolar region and pulmonary arteries was also evident. (Supplementary Fig. 3)

Fig. 6
figure 6

Recruitment of inflammatory cells to the small airways and inflammatory mediators in BAL fluid. Eosinophil (black arrow head, A) infiltrated around small airways increased significantly in rats exposed DEP for 4 weeks and 8 weeks (** p < 0.01, B). For the mast cells (red arrows head, C), exposure of rats to DEP for 8 weeks (* p < 0.05, D), but not for shorter durations, demonstrated a significant increase around the small airways. The infiltrations of Iba-1 immuno-positive macrophages (blue arrow head, E) were significantly increased in small airways following 4-wk (*** p < 0.001) or 8-wk DEP exposure (** p < 0.01), as compared to the filtered air controls, respectively (F). Bar in the images (Panel A, C, E) = 100 μm. ns = not significant. SA = small airways. Cell differentials in BALF showed significant increases of total leukocyte, macrophage as well as neutrophil, but not eosinophils, following 8-week DEP exposure, as compared to filtered air control, respectively (** p < 0.01, ns, not significant, G-J). DEP exposure for 4-wk or 8-wk significantly increased BALF concentrations of TNF-α, IL-6, IL-13 and IL-17 A, respectively (** p < 0.01, ns, not significant, K-N). Data were expressed as mean (95% CI)

Full size image

As another immune effector cell, we observed significant infiltrations of mast cells in the submucosa of small airways in rats exposed to DEP for 8-week [2.7 (1.4–3.9)/ mm BM vs. 1.3 (0.4–2.3)/ mm BM] as compared to filtered air control (Fig. 6C-D). We also found significant increases of Ibal-1 positive macrophages in submucosal layer of the small airways following exposures to DEP for 4-week [24.9 (19.3–30.5)/mm BM vs. 8.9 (4.5–12.7)/mm BM] and 8-week (27.3 (16.8–37.3)/mm BM vs. 8.8 (5.0-12.9)/mm BM) (Fig. 6E-F). However, we did not find evident infiltration of neutrophil in rats’ peripheral lung. As compared to filter air controls, exposure of rats to DEP over 2-week to 8-week did not induce significant increases in neutrophil infiltration around the small airways (Supplementary Fig. 4).

Increased level of inflammatory mediators in BALF upon DEP exposures

To determine the inflammatory response of the rats’ lung, we measured the inflammatory cell differential and cytokine levels in BALF. Compared with those following the filtered air exposures, counts of total cells, macrophages, and neutrophils in BALF were all significantly higher following the 8-wk DEP exposure (p < 0.01) (Fig. 6, G-I); neutrophil counts were also significantly increased following the 4-wk DEP exposure (p < 0.001). We observed an increasing trend of eosinophil count in BAL fluid following DEP exposures, though the difference did not reach statistical significance (p > 0.05) (Fig. 6, J). Compared to the filtered air controls, both 4-wk and 8-wk DEP exposures resulted in significant increases in BALF concentrations of pro-inflammatory cytokines, including TNF-α, IL-6, IL-13 and IL-17 A (Fig. 6, K-N). However, the concentration of IL-5 in BALF did not change significantly following DEP exposures (Supplementary Fig. 5).

DEP exposure induced systemic oxidative stress

Systemic effects of DEP exposures were assessed using serum malondialdehyde (MDA, a product of lipid peroxidation) and 8-hydroxy-deoxyguanosine (8-OhdG, a product of DNA oxidation). Compared to the filtered air control, 4-wk and 8-wk DEP exposures induced a significant increase in 8-OhdG concentration, respectively (Fig. 7. A). We also observed a significant increase in serum MDA concentration following DEP exposures of any duration (Fig. 7. B).

Fig. 7
figure 7

Oxidative stressor concentrations. As compared to filtered air control, the serum levels of 8-OHdG increased significantly in rats exposed to DEP for 4-wk or 8-wk (** p < 0.01, *** p < 0.001, A). Exposure of rats to DEP for 3 durations resulted in significant increases of serum MDA levels, as compared to the control, respectively (* p < 0.05, *** p < 0.001, B). Data were expressed as mean (95% CI)

Full size image

Discussion

The principal novel finding of the present study is that repeated DEP exposures caused small airway remodeling as the initial site of injury, consequently leading to the development of COPD with an eosinophilic phenotype in a rat model. Our rat model (healthy SD rats) represents the healthy lung. The DEP, containing common elements and organic compounds, was generated freshly from a diesel engine, represented a surrogate of traffic related urban PM2.5. The present study, on the other hand, was designed to mainly elucidate the pathophysiologic processes underlying the development of COPD upon DEP exposure.

Emerging evidence in humans has suggested that chronic PM2.5 exposure may affect small airway structure and function. For example, Churg et al. found an association between high level of ambient particulate matter and small airway remodeling in residents living near traffic roads [31]. Wang et al. showed that long-term exposure to ambient PM2.5 or black carbon correlated significantly with computed tomographic defining emphysema in adults [32]. Liu et al. suggested that chronic exposure to diesel exhaust may be related to small airway wall thickening in diesel engine testers [33]. In the present study, we confirmed the causal effects of DEP exposure on small airway remodeling as well as lung emphysema and associated lung function impairments.

Our morphologic analysis showed that relative total wall area (WAt) of the small airways in DEP-exposed rats was about 2-fold larger as compared to those in the filtered air control. Also noted were the increased expression of α-SMA in small airway wall. These interesting pathologic phenomena indicate that small airway remodeling remained an earlier adverse event following DEP exposure. In addition, fibrosis of the lung was evident in DEP-exposed rats, as indicated by the increased level of hydroxyproline in lung homogenates. Furthermore, we found significant increase in fibrotic area of the small airways but not larger airways, suggesting small airways are more vulnerable to the adverse effects induced by DEP. Exposure of rats to DEP induced phenotypic changes of goblet cell hyperplasia and mucus hypersecretions in small airways. Being the place where the gases shift from bulk flow to diffusion occurs, the small airway has been hypothesized as the primary target for the impaction of PM2.5 inhaled into the lungs [34, 35]. One the other hand, it has been shown that the mucus and ciliated cells decreased from the large conducting airways to peripheral airways [36]. In this case, the small airways might be less potent in the mucociliary clearance of inhaled DEP. Indeed, inhalation of aerosol particles ranged in smaller sizes (typical of DEP) has been shown to deposit mainly in the small airways of rodents [21, 22]. Taken together, small airway impairment might represent an important pathophysiologic process in DEP-induced COPD.

Exposure of rats to DEP also induced emphysematous alterations of the lung, as revealed by the significant enlargement of the alveoli. Although the presence of lung emphysema following 4-week DEP exposure was later than that of small airway remodeling following 2-week DEP exposure, increased expressions of α-SMA was also observed in the alveolar region. As a phenotypic marker of epithelial to mesenchymal transition (EMT), alterations of α-SMA expression have been implicated in peripheral lung of COPD patients [37, 38] or in cigarette-induced COPD mice [39]. Thus, the phenotypic changes in alveolar region might be another pathological process involved in DEP-induced COPD.

DEPs are mostly ultrafine or nanoscale particles. In this study, we showed that black carbon was phagocyted by alveolar macrophages in a dose-dependent fashion (the longer DEP exposure was, the larger the carbon-loaded area was.) This indicates that DEP reached deep into the peripheral airways. Due to their small particle size, DEP posed large relative surface area that allowed for containing various toxic substances. Through chemical analysis, we identified various metal elements and PAHs that accounted for 0.71% and 0.37% of the total mass of DEP, respectively. Transitional metals, especially Fe, are potent oxidative stressors in inducing the generation of reactive oxygen species (ROS) [40]. DEP containing PAHs or oxygenated-PAHs, such as Benzo(a)pyrene and quinone, have been shown to stimulate the releases of ROS in airway epithelial cells as well as macrophages [41, 42]. Excessive ROS produced in target cells can heighten the peroxidation of cell membrane lipids and attacks DNA molecules, which lead to the elevated production of MDA and 8-OHdDG that seen in this model.

Inflammatory responses of the airways are the core feature of chronic airway diseases. In the present study, we found significant airway inflammation characterized by increased numbers of macrophages and neutrophils in BALF following DEP exposure, consistent to previous studies [43, 44]. In addition, a dramatic infiltration of eosinophils to the peripheral lung, including the small airways and alveoli, was observed in DEP-exposed rats. Accumulation of eosinophils in lung tissues has been shown to contribute to airspace enlargement and alveolar destruction in mice [45]. Significantly increased levels of type 2 cytokines, e.g., IL-13, IL-4 and TNF-α, but not IL-5, and an increasing trend of eosinophil count were exhibited in the BALF. Eosinophils are terminally differentiated, bone marrow-derived, granule-containing leukocytes, which are potent drivers of inflammatory damage, airway remodeling and fibrosis through secreting type 2 cytokines as well as various enzyme-containing granules [46]. Although the exact mechanisms underlying DEP-induced lung eosinophilia are unclear, we inferred that DEP-induced eosinophil recruitment to the peripheral lung might be related to an IL-5 independent mechanism. For example, previous studies have shown that type 2-promoting cytokines, such as IL-33 [47] and TSLP [48] released by DEP-exposed airway epithelial cells, are involved in pollutant-induced eosinophilic airway inflammation. In addition, DEP per se may act as allergen carriers that absorbed various allergens, such as pollen, dust mites and pathogens [49, 50], which might enhance eosinophil recruitment to the peripheral lungs in DEP-exposed rats. Likewise, previous studies have shown that eosinophilic inflammation was evident in biomass smoke-related COPD, but the majority of cell population in the sputum was neutrophil [17, 51], which is consistent with our current findings. In addition, the lack of neutrophil recruitment to the airway mucosa might be due to the rapid transition of this cell type from tissue to the airway lumen that has been observed in COPD patients [52].

COPD is a complex and heterogeneous disease that may result from different etiologies and risk factors. Two main causative agents, such as cigarette smoke (CS) and biomass smoke (BS), have been widely applied to model COPD in experimental studies. Pathologic findings showed that emphysema was the major phenotype in CS-related COPD, while small airway remodeling and fibrosis were predominant in BS-related COPD [53, 54]. As another risk factor for incident COPD, we showed that DEP-related COPD could manifest as small airway remodeling and emphysema, along with significant eosinophil infiltrations. Although BALF neutrophils were the primary cell type found to be increased following DEP exposure, we did not observe evident neutrophilic infiltration in the peripheral lung. We propose that eosinophil recruitment to the small airways and alveolar regions might represent a distinct feature in DEP-related COPD.

We conducted the experiments in a diesel chamber with steady meteorological conditions. There were no notable infections or deaths of rats during DEP exposures. Being the first in vivo model to demonstrate the pathophysiologic features of DEP-induced COPD, however, the present study has some limitations. First, although injuries of the small airways were evident following DEP exposures, the molecular mechanisms underlying the involved pathophysiologic processes remain to be further elucidated. Also, the pathologic alterations and inflammatory phenotype in long-term DEP exposure need future investigations. Second, freshly generated DEP contains a mixture of various constituents, some of which have been identified in this study. However, the oxidative potential and toxicity between fresh DEP and aged DEP in atmospheric environment are different [55]. In this case, caution should be made when explaining the adverse effects of fresh DEP and real-world PM2.5. Third, in addition to T2-driven inflammation, increased number of CD8 + T-lymphocytes and Th1-driven inflammatory response has been shown to play important roles in the pathogenesis of COPD [56, 57]. We wish to evaluate these phenotypic changes in DEP-related COPD in the future. Finally, we did not take age into account in evaluating the adverse effects of DEP. Previous publications have shown that age can impact the response to particulate matter pollution exposure in a murine model [58, 59]. Hence, future studies are recommended to examine how age modifies the contribution of PM2.5 exposure to the development of COPD.

Conclusions

In summary, this study adds novel findings to the existing knowledge on the role of particulate pollution and the role of the small airways in the pathophysiology and environmental etiology of COPD. Our findings suggest that DEP exposure contributes to the etiology of COPD with a distinct eosinophilic infiltration in the peripheral lung.

Data Availability

The raw data required to reproduce these findings are available within the article and the supplementary files. Data are available from the corresponding author upon reasonable request.

Abbreviations

α-SMA:

Alpha smooth muscle actin

8-OHdG:

8-hydroxy-2’-deoxyguanosine

BALF:

Bronchoalveolar lavage fluid

BM:

Basement membrane

COPD:

Chronic obstructive pulmonary disease

DEP:

Diesel exhaust particle

EC:

Elemental carbon

MDA:

Malondialdehyde

MLI:

Mean linear intercept

OC:

Organic carbon

PAH:

Polycyclic aromatic hydrocarbons

PM2.5 :

Particulate matter with aerodynamic diameter < 2.5 μm

PMC:

Particle mass concentration

PNC:

Particle number concentration

WAt:

Total wall areas

References

  1. Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–96. https://0-doi-org.brum.beds.ac.uk/10.1016/s2213-2600(20)30105-3

    Article  Google Scholar 

  2. Global strategy for the prevention, diagnosis and management of COPD. 2019 GOLD report. Available from: https://goldcopd.org/gold-reports/. Accessed 8 October 2023.

  3. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–43; https://0-doi-org.brum.beds.ac.uk/10.1016/S0140-6736(09)61303-9

  4. Syamlal G. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and occupation-United States, 2013–2017. MMWR morbidity and mortality weekly report. 2019;68:303–7. https://0-doi-org.brum.beds.ac.uk/10.15585/mmwr.mm6813a2

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med. 2022;10(5):497–511. https://0-doi-org.brum.beds.ac.uk/10.1016/S2213-2600(21)00506-3

    Article  Google Scholar 

  6. Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–17. https://0-doi-org.brum.beds.ac.uk/10.1016/s0140-6736(18)30841-9

    Article  Google Scholar 

  7. Doiron D, de Hoogh K, Probst-Hensch N, Fortier I, Cai Y, De Matteis S, et al. Air pollution, lung function and COPD: results from the population-based UK Biobank study. Eur Respir J. 2019;54:1. https://0-doi-org.brum.beds.ac.uk/10.1183/13993003.02140-2018

    Article  CAS  Google Scholar 

  8. Shin S, Bai L, Burnett RT, Kwong JC, Hystad P, van Donkelaar A, et al. Air pollution as a risk factor for incident COPD and asthma: 15-year population-based cohort study. Am J Respir Crit Care Med. 2020;203(9):1138–48. https://0-doi-org.brum.beds.ac.uk/10.1164/rccm.201909-1744OC

    Article  Google Scholar 

  9. Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sorensen M, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med. 2011;183:4455–61. https://0-doi-org.brum.beds.ac.uk/10.1164/rccm.201006-0937OC

    Article  CAS  Google Scholar 

  10. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, et al. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res. 2005;6:152. https://0-doi-org.brum.beds.ac.uk/10.1186/1465-9921-6-152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Thurston GD, Balmes JR, Garcia E, Gilliland FD, Rice MB, Schikowski T, et al. Outdoor air pollution and new-onset airway disease. An official American thoracic society workshop report. Ann Am Thorac Soc. 2020;17:4387–98. https://0-doi-org.brum.beds.ac.uk/10.1513/AnnalsATS.202001-046ST

    Article  Google Scholar 

  12. Hogg JC, Macklem PT, Thurlbeck W. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–60. https://0-doi-org.brum.beds.ac.uk/10.1056/NEJM196806202782501

    Article  Google Scholar 

  13. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–75. https://0-doi-org.brum.beds.ac.uk/10.1056/NEJMoa1106955

    Article  Google Scholar 

  14. Xiao D, Chen Z, Wu S, Huang K, Xu J, Yang L, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081–93. https://0-doi-org.brum.beds.ac.uk/10.1016/s2213-2600(20)30155-7

    Article  Google Scholar 

  15. Cui X, Li F, Xiang J, Fang L, Chung MK, Day DB, et al. Cardiopulmonary effects of overnight indoor air filtration in healthy non-smoking adults: a double-blind randomized crossover study. Environ Int. 2018;114:27–36. https://0-doi-org.brum.beds.ac.uk/10.1016/j.envint.2018.02.010

    Article  CAS  PubMed  Google Scholar 

  16. Cui X, Li Z, Teng Y, Barkjohn KK, Norris CL, Fang L, et al. Association between bedroom particulate matter filtration and changes in airway pathophysiology in children with asthma. JAMA Pediatr. 2020;174(6):533–42. https://0-doi-org.brum.beds.ac.uk/10.1001/jamapediatrics.2020.0140

    Article  Google Scholar 

  17. Fernandes L, Rane S, Mandrekar S, Mesquita AM. Eosinophilic Airway Inflammation in patients with stable biomass smoke- versus tobacco smoke-associated chronic obstructive pulmonary disease. J Health Pollut. 2019;9:24. https://0-doi-org.brum.beds.ac.uk/10.5696/2156-9614-9.24.191209

    Article  Google Scholar 

  18. Falfán-Valencia R, Ramírez-Venegas A, Pérez Lara-Albisua JL, Ramírez-Rodriguez SL, Márquez-García JE, Buendía-Roldan I, et al. Smoke exposure from chronic biomass burning induces distinct accumulative systemic inflammatory cytokine alterations compared to tobacco smoking in healthy women. Cytokine. 2020;131:155089. https://0-doi-org.brum.beds.ac.uk/10.1016/j.cyto.2020.155089

    Article  CAS  PubMed  Google Scholar 

  19. Grytting VS, Chand P, Lag M, Ovrevik J, Refsnes M. The pro-inflammatory effects of combined exposure to diesel exhaust particles and mineral particles in human bronchial epithelial cells. Part Fibre Toxicol. 2022;19(1:14). https://0-doi-org.brum.beds.ac.uk/10.1186/s12989-022-00455-0

  20. Long E, Carlsten C. Controlled human exposure to diesel exhaust: results illuminate health effects of traffic-related air pollution and inform future directions. Part Fibre Toxicol. 2022;19(1). https://0-doi-org.brum.beds.ac.uk/10.1186/s12989-022-00450-5

  21. Guo C, Buckley A, Marczylo T, Seiffert J, Römer I, Warren J et al. The small airway epithelium as a target for the adverse pulmonary effects of silver nanoparticle inhalation. Nanotoxicology 2018:1–15; https://0-doi-org.brum.beds.ac.uk/10.1080/17435390.2018.1465140

  22. Laiman V, Hsiao TC, Fang YT, Chen YY, Lo YC, Lee KY, et al. Hippo signaling pathway contributes to air pollution exposure-induced emphysema in ageing rats. J Hazard Mater. 2023;452:131188. https://0-doi-org.brum.beds.ac.uk/10.1016/j.jhazmat.2023.131188

    Article  CAS  PubMed  Google Scholar 

  23. Chen Z, Chen F, Fang Z, Zhao H, Zhan C, Li C, et al. Glial activation and inflammation in the NTS in a rat model after exposure to diesel exhaust particles. Environ Toxicol Pharmacol. 2021;83:103584. https://0-doi-org.brum.beds.ac.uk/10.1016/j.etap.2021.103584

    Article  CAS  PubMed  Google Scholar 

  24. Franken R, Maggos T, Stamatelopoulou A, Loh M, Kuijpers E, Bartzis J, et al. Comparison of methods for converting Dylos particle number concentrations to PM2.5 mass concentrations. Indoor Air. 2019;29(3):450–9. https://0-doi-org.brum.beds.ac.uk/10.1111/ina.12546

    Article  CAS  Google Scholar 

  25. He L-Y, Hu M, Zhang Y-H, Huang X-F, Yao T-T. Fine particle emissions from on-road vehicles in the Zhujiang tunnel, China. Environ Sci Technol. 2008;42(12):4461–6. https://0-doi-org.brum.beds.ac.uk/10.1021/es7022658

    Article  CAS  Google Scholar 

  26. Palmans E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med. 2000;161(2 Pt 1):627–35. https://0-doi-org.brum.beds.ac.uk/10.1164/ajrccm.161.2.9902094

    Article  CAS  PubMed  Google Scholar 

  27. Sapienza S, Du T, Eidelman DH, Wang NS, Martin JG. Structural changes in the airways of sensitized Brown Norway rats after antigen challenge. Am Rev Respir Dis. 1991;144(2):423–7. https://0-doi-org.brum.beds.ac.uk/10.1164/ajrccm/144.2.423

    Article  Google Scholar 

  28. Bai A, Eidelman DH, Hogg JC, James AL, Lambert RK, Ludwig MS, et al. Proposed nomenclature for quantifying subdivisions of the bronchial wall. J Appl Physiol. 1994;77(2):1011–4. https://0-doi-org.brum.beds.ac.uk/10.1152/jappl.1994.77.2.1011

    Article  Google Scholar 

  29. Fang Z, Huang C, Zhang JJ, Xie J, Dai S, Ge E, et al. Traffic-related air pollution induces non-allergic eosinophilic airway inflammation and cough hypersensitivity in guinea-pigs. Clin Exp Allergy. 2019;49:3366–77. https://0-doi-org.brum.beds.ac.uk/10.1111/cea.13308

    Article  CAS  Google Scholar 

  30. Xu M, Wang L, Wang M, Wang H, Zhang H, Chen Y, et al. Mitochondrial ROS and NLRP3 inflammasome in acute ozone-induced murine model of airway inflammation and bronchial hyperresponsiveness. Free Radic Res. 2019;53:7780–90. https://0-doi-org.brum.beds.ac.uk/10.1080/10715762.2019.1630735

    Article  CAS  Google Scholar 

  31. Churg A, Brauer M, del Carmen Avila-Casado M, Fortoul T, Wright J. Chronic exposure to high levels of particulate air pollution and small airway remodeling. Environ Health Perspect. 2003;111(5):714–8. https://0-doi-org.brum.beds.ac.uk/10.1289/ehp.6042

    Article  CAS  Google Scholar 

  32. Wang M, Aaron CP, Madrigano J, Hoffman EA, Angelini E, Yang J, et al. Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function. JAMA. 2019;322(6):546–56. https://0-doi-org.brum.beds.ac.uk/10.1001/jama.2019.10255

    Article  CAS  Google Scholar 

  33. Liu H, Li J, Ma Q, Tang J, Jiang M, Cao X, et al. Chronic exposure to diesel exhaust may cause small airway wall thickening without lumen narrowing: a quantitative computerized tomography study in Chinese diesel engine testers. Part Fibre Toxicol. 2021;18:1. https://0-doi-org.brum.beds.ac.uk/10.1186/s12989-021-00406-1

    Article  CAS  Google Scholar 

  34. Hogg J, Paré P, Hackett T. The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 2017;97(2):529–52. https://0-doi-org.brum.beds.ac.uk/10.1152/physrev.00025.2015

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hogg JC, Hackett TL. Structure and function relationships in diseases of the small airways. Ann Am Thorac Soc. 2018;15 Supplement_1:S18-S25. https://0-doi-org.brum.beds.ac.uk/10.1513/AnnalsATS.201710-809KV

  36. Tata PR, Rajagopal J. Plasticity in the lung: making and breaking cell identity. Development. 2017;144(5):755–66. https://0-doi-org.brum.beds.ac.uk/10.1242/dev.143784

    Article  CAS  Google Scholar 

  37. Karvonen HM, Lehtonen ST, Harju T, Sormunen RT, Lappi-Blanco E, Mäkinen JM, et al. Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Respir Res. 2013;14:84. https://0-doi-org.brum.beds.ac.uk/10.1186/1465-9921-14-84

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mori M, Andersson CK, Graham GJ, Löfdahl CG, Erjefält JS. Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD. Respir Res. 2013;14:65. https://0-doi-org.brum.beds.ac.uk/10.1186/1465-9921-14-65

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Han H, Peng G, Meister M, Yao H, Yang JJ, Zou MH, et al. Electronic cigarette exposure enhances lung inflammatory and fibrotic responses in COPD mice. Front Pharmacol. 2021;12:726586. https://0-doi-org.brum.beds.ac.uk/10.3389/fphar.2021.726586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Verma V, Shafer MM, Schauer JJ, Sioutas C. Contribution of transition metals in the reactive oxygen species activity of PM emissions from retrofitted heavy-duty vehicles. Atmos Environ. 2010;44(39):5165–73. https://0-doi-org.brum.beds.ac.uk/10.1016/j.atmosenv.2010.08.052

    Article  CAS  Google Scholar 

  41. Li N, Wang M, Oberley TD, Sempf JM, Nel AE. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J Immunol. 2002;169(8):4531–41. https://0-doi-org.brum.beds.ac.uk/10.4049/jimmunol.169.8.4531

    Article  Google Scholar 

  42. Wang E, Liu X, Tu W, Do DC, Yu H, Yang L, et al. Benzo(a)pyrene facilitates dermatophagoides group 1 (Der f 1)-induced epithelial cytokine release through aryl hydrocarbon receptor in asthma. Allergy. 2019;74(9):1675–90. https://0-doi-org.brum.beds.ac.uk/10.1111/all.13784

    Article  CAS  Google Scholar 

  43. Decaesteker T, Vanhoffelen E, Trekels K, Jonckheere AC, Cremer J, Vanstapel A, et al. Differential effects of intense exercise and pollution on the airways in a murine model. Part Fibre Toxicol. 2021;18(1):12. https://0-doi-org.brum.beds.ac.uk/10.1186/s12989-021-00401-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Singh N, Arora N. Diesel exhaust exposure in mice induces pulmonary fibrosis by TGF-beta/Smad3 signaling pathway. Sci Total Environ. 2022;807:150623. https://0-doi-org.brum.beds.ac.uk/10.1016/j.scitotenv.2021.150623

    Article  CAS  PubMed  Google Scholar 

  45. Doyle AD, Mukherjee M, LeSuer WE, Bittner TB, Pasha SM, Frere JJ, et al. Eosinophil-derived IL-13 promotes emphysema. Eur Respir J. 2019;53(5):1801291. https://0-doi-org.brum.beds.ac.uk/10.1183/13993003.01291-2018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Gieseck RL III, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18(1):62. https://0-doi-org.brum.beds.ac.uk/10.1038/nri.2017.90

    Article  CAS  Google Scholar 

  47. De Grove KC, Provoost S, Braun H, Blomme EE, Teufelberger AR, Krysko O, et al. IL-33 signalling contributes to pollutant-induced allergic airway inflammation. Clin Exp Allergy. 2018;48(12):1665–75. https://0-doi-org.brum.beds.ac.uk/10.1111/cea.13261

    Article  CAS  Google Scholar 

  48. Brandt EB, Bolcas PE, Ruff BP, Khurana Hershey GK. TSLP contributes to allergic airway inflammation induced by diesel exhaust particle exposure in an experimental model of severe asthma. Clin Exp Allergy. 2020;50(1):121–4. https://0-doi-org.brum.beds.ac.uk/10.1111/cea.13512

    Article  CAS  PubMed  Google Scholar 

  49. Knox R, Suphioglu C, Taylor P, Desai R, Watson HC, Peng J-L, et al. Major grass pollen allergen lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy. 1997;27(3):246–51. https://0-doi-org.brum.beds.ac.uk/10.1111/j.1365-2222.1997.tb00702.x

    Article  CAS  PubMed  Google Scholar 

  50. Ormstad H, Johansen B, Gaarder P. Airborne house dust particles and diesel exhaust particles as allergen carriers. Clin Exp Allergy. 1998;28(6):702–8. https://0-doi-org.brum.beds.ac.uk/10.1046/j.1365-2222.1998.00302.x

    Article  Google Scholar 

  51. Sansores RH, Paulin-Prado P, Robles-Hernández R, et al. Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure. Respir Med. 2022;204:107010. https://0-doi-org.brum.beds.ac.uk/10.1016/j.rmed.2022.107010

    Article  PubMed  Google Scholar 

  52. Lacoste J-Y, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;92(4):537–48. https://0-doi-org.brum.beds.ac.uk/10.1016/0091-6749(93)90078-t

    Article  CAS  PubMed  Google Scholar 

  53. Ghorani V, Boskabady MH, Khazdair MR, Kianmeher M. Experimental animal models for COPD: a methodological review. Tob Induc Dis. 2017;15(1):25. https://0-doi-org.brum.beds.ac.uk/10.1186/s12971-017-0130-2

    Article  CAS  Google Scholar 

  54. Ramírez-Venegas A, Torres-Duque CA, Guzmán-Bouilloud NE, González-García M, Sansores RH. Small airway disease in COPD associated to biomass exposure. Rev Invest Clin. 2019;71:70–8. https://0-doi-org.brum.beds.ac.uk/10.24875/RIC.18002652

    Article  PubMed  Google Scholar 

  55. Weitekamp CA, Stevens T, Stewart MJ, Bhave P, Gilmour MI. Health effects from freshly emitted versus oxidatively or photochemically aged air pollutants. Sci Total Environ. 2020;704:135772. https://0-doi-org.brum.beds.ac.uk/10.1016/j.scitotenv.2019.135772

    Article  CAS  PubMed  Google Scholar 

  56. Saetta M, Di Stefano A, Turato G, Facchini F, Corbino L, Mapp C, et al. CD8 + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822–6. https://0-doi-org.brum.beds.ac.uk/10.1164/ajrccm.157.3.9709027

    Article  CAS  PubMed  Google Scholar 

  57. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1:e8. https://0-doi-org.brum.beds.ac.uk/10.1371/journal.pmed.0010008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Qin G, Xia J, Zhang Y, Guo L, Chen R, Sang N. Ambient fine particulate matter exposure induces reversible cardiac dysfunction and fibrosis in juvenile and older female mice. Part Fibre Toxicol. 2018;15:27. https://0-doi-org.brum.beds.ac.uk/10.1186/s12989-018-0264-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Lee JW, Kim JS, Lee HJ, Jang JH, Kim JH, Sim WJ. e al. Age and gender effects on genotoxicity in diesel exhaust particles exposed C57BL/6 mice. Biomolecules. 2021;11:374. https://0-doi-org.brum.beds.ac.uk/10.3390/biom11030374

Download references

Acknowledgements

The authors would like to thank Dr. Xin-hui Bi, Dr. Fang He, Dr. Pi-xin Ran and Dr. Wen-ju Lu for their technical support with this study.

Funding

This work was funded by grants from National Natural Science Foundation of China (Grant Number: 82000024, 82270035, 81900100), the projects from State Key Laboratory of Respiratory Disease (SKLRD-Z-202119 and SKLRD-OP-202211), and Shenzhen Science and Technology Program (JCYJ20220530151213031, GJHZ20190821173801659, GJHZ20190822095605512, JSGG20200225153031960, SGDX20201103095609027).

Author information

Authors and Affiliations

  1. Department of Respirology & Allergy, Third Affiliated Hospital of Shenzhen University, Shenzhen, 518020, China

    Zhang-fu Fang

  2. State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China

    Zhang-fu Fang, Zhao-ni Wang, Yang Peng, Yu Fu, Yang Yang, Jia-xing Xie & Nan-shan Zhong

  3. Laboratory of Cough, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, 215300, Jiangsu, China

    Zhe Chen

  4. Global Health Research Center, Duke Kunshan University, Kunshan, 215316, Jiangsu Province, China

    Hai-long Han, Yan-bo Teng & Junfeng (Jim) Zhang

  5. State Key Laboratory of Respiratory Disease Allergy Division at Shenzhen University, Institute of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, 518061, China

    Wei Zhou, Damo Xu & Xiao-yu Liu

  6. Nicholas School of the Environment and Global Health Institute, Duke University, Durham, NC, 27708, USA

    Junfeng (Jim) Zhang

  7. Guangzhou Laboratory, Guangzhou, 510000, China

    Nan-shan Zhong

Authors
  1. Zhang-fu Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhao-ni Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhe Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hai-long Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yan-bo Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wei Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Damo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiao-yu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jia-xing Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Junfeng (Jim) Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nan-shan Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Z.F., JX., J.Z., and N.Z. designed the study. Z.F., Z.W., Z.C., Y.P., Y.F., Y.Y., H.H., Y.T., W.Z., and X.L. collected and analyzed the data. Z.F., Z.W., Z.C., Y.P., D.X., and J.Z. prepared the manuscript. Z.F., J.X., J.Z., and N.Z. discussed the results and critically revised the manuscript. All authors reviewed and approved the final manuscript.

Corresponding authors

Correspondence to Jia-xing Xie, Junfeng (Jim) Zhang or Nan-shan Zhong.

Ethics declarations

Ethics approval

The animal experimental protocols were approved by the Animal Care and Use Committee of Guangzhou Medical University and confirmed to the Guide for the Care and Use of Laboratory Animals.

Consent for publication

Not Applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1: Figure S1.

Whole lung morphologic showing large airway with perimeter > 2000 μm (LA, Red box), small airway with perimeter ≤ 1000 μm (SA, Blue box), pulmonary artery with diameter between 50–150 μm (PA, Blue box) and alveolar region (Green box). Bar = 1000 μm. Figure S2. Fibrosis quantification of the large airways. Fibrosis areas around the large airways with perimeter > 2000 μm showed an increasing trend, but did not reach statistical significance following 2wk to 8-wk DEP exposures, respectively. Bar in the Masson Trichrome staining image = 100 μm. n = 6 rats/group. ns = not significant. Figure S3. Recruitment of eosinophils (black arrows) to the alveolar region (Panel A) and pulmonary arteries (Panel C). Eosinophil infiltrated in the alveolar increased significantly in rats exposed DEP for 4 weeks and 8 weeks (B). Rats exposed to DEP for 4 weeks and 8 weeks, but not for shorter durations, demonstrated a significant increase of eosinophils around the PA (D). Bar in the C2R staining image = 100μm. * p < 0.05, *** p < 0.001. n = 6 rats/group. PA = pulmonary arteries. Figure S4. Representative images of IHC staining of neutrophils in small airways, showing the recruitment of neutrophils (red arrows) around the small airways in DEP exposure group and the control group, by exposure duration (Panel A). T-tests showed that neutrophil infiltration of the small airways did not reach statistical difference between the DEP exposure groups and filtered air controls (Panel B). Magnification of IHC staining image, lower panel, 1000x, n = 6 rats/group. ns = not significant. Figure S5. DEP exposures over the courses of 2-wk to 8-wk did not significantly change the concentrations of IL-5 in BALF. ns = not significant

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fang, Zf., Wang, Zn., Chen, Z. et al. Fine particulate matter contributes to COPD-like pathophysiology: experimental evidence from rats exposed to diesel exhaust particles. Respir Res 25, 14 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12931-023-02623-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12931-023-02623-y

Keywords

Respiratory Research

ISSN: 1465-993X

Contact us